This is according to ElleVet Sciences. The company has published the results of a controlled clinical trial exploring the use of its proprietary CBD + CBDA Oil and its efficacy on dogs experiencing seizures.
A research team led by Gabriel Garcia, DVM, DACVIM (Neurology) of the University of Florida (UF) Veterinary School conducted a two-year study, examining a three-month-long treatment whereby enrolled dogs received either a placebo or CBD oil.
When compared to the placebo group, the frequency and severity of seizures dropped “significantly” for 40 percent of dogs receiving CBD, the findings show.
While CBD has been widely believed to have potential as an option for seizures in dogs, there have been few studies on the topic prior to this study showing efficacy in dogs, ElleVet Sciences reports.
“It is not surprising to us that there were positive results, as CBD has been used in the human realm for some time,” says ElleVet Sciences’ co-founder, Amanda Howland. “What was surprising was the low dose that is needed of our full spectrum product compared to CBD isolate used in human studies.”
All dogs enrolled were on concurrent seizure products with no adverse events occurring.
“This can be a regimen that is safe and effective and is a worthwhile addition to the current regimen for refractory seizures when commonly used products are not working as well as intended,” says ElleVet Sciences’ chief medical officer, Joe Wakshlag, DVM, PhD.
The findings have been published in Frontiers of Veterinary Medicine. For more, click here.